Display options
Share it on

BMC Proc. 2014 Jun 17;8:S104. doi: 10.1186/1753-6561-8-S1-S104. eCollection 2014.

Integrated statistical and pathway approach to next-generation sequencing analysis: a family-based study of hypertension.

BMC proceedings

Jeremy S Edwards, Susan R Atlas, Susan M Wilson, Candice F Cooper, Li Luo, Christine A Stidley

Affiliations

  1. Molecular Genetics and Microbiology, and Chemical and Nuclear Engineering, 1 University of New Mexico, University of New Mexico Cancer Center, Albuquerque, NM 87131, USA.
  2. Physics and Astronomy, Center for Advanced Research Computing, 1 University of New Mexico, University of New Mexico Cancer Center, Albuquerque, NM 87131, USA.
  3. Center for Advanced Research Computing, University of New Mexico Cancer Center, 1 University of New Mexico, Albuquerque, NM 87131, USA.
  4. University of New Mexico Cancer Center, Internal Medicine, 1 University of New Mexico, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

PMID: 25519358 PMCID: PMC4143684 DOI: 10.1186/1753-6561-8-S1-S104

Abstract

Genome wide association studies (GWAS) have been used to search for associations between genetic variants and a phenotypic trait of interest. New technologies, such as next-generation sequencing, hold the potential to revolutionize GWAS. However, millions of polymorphisms are identified with next-generation sequencing technology. Consequently, researchers must be careful when performing such a large number of statistical tests, and corrections are typically made to account for multiple testing. Additionally, for typical GWAS, the p value cutoff is set quite low (approximately <10(-8)). As a result of this p value stringency, it is likely that there are many true associations that do not meet this threshold. To account for this we have incorporated a priori biological knowledge to help identify true associations that may not have reached statistical significance. We propose the application of a pipelined series of statistical and bioinformatic methods, to enable the assessment of the association of genetic polymorphisms with a disease phenotype--here, hypertension--as well as the identification of statistically significant pathways of genes that may play a role in the disease process.

References

  1. Nat Med. 2006 Jul;12(7):841-5 - PubMed
  2. Cell. 2001 Feb 23;104(4):545-56 - PubMed
  3. Bioessays. 2000 May;22(5):442-51 - PubMed
  4. Harvey Lect. 2004-2005;100:71-101 - PubMed
  5. Hum Mol Genet. 2009 Jun 15;18(12):2288-96 - PubMed
  6. BMC Med Genet. 2007 Sep 19;8 Suppl 1:S3 - PubMed
  7. Cardiovasc Res. 2006 Jun 1;70(3):410-21 - PubMed
  8. Trends Genet. 2012 Aug;28(8):397-408 - PubMed
  9. Genome Med. 2009 Apr 28;1(4):43 - PubMed
  10. Nat Genet. 2008 May;40(5):592-9 - PubMed
  11. Eur J Hum Genet. 2008 Dec;16(12):1507-11 - PubMed
  12. Hum Hered. 2006;61(1):10-4 - PubMed
  13. Pharmacogenomics J. 2013 Aug;13(4):330-4 - PubMed
  14. Stat Med. 2005 Oct 15;24(19):2911-35 - PubMed
  15. Hum Mol Genet. 2011 Jun 1;20(11):2285-95 - PubMed
  16. Cardiovasc Res. 2004 Jan 1;61(1):11-21 - PubMed
  17. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):226-31 - PubMed
  18. Nature. 2007 Jun 7;447(7145):661-78 - PubMed
  19. Circ J. 2012;76(4):907-13 - PubMed
  20. Nat Rev Cardiol. 2010 Nov;7(11):637-47 - PubMed
  21. Diabetes. 2005 Sep;54(9):2655-62 - PubMed
  22. PLoS One. 2012;7(3):e32907 - PubMed

Publication Types

Grant support